Al Nour Eye Hospital
Giza, Egypt
NCT Number: NCT02210793
The aim of the study is to evaluate the severity of dry eye syndrome following excimer laser vision correction using no-touch all-laser photorefractive keratectomy in comparison to conventional lasik
Looking for future studies?
Notify Me18 year–40 year
All sexes
Interventional
Not applicable
Giza, Egypt
Prospective interventional clinical study 2 groups: Group A : 20 eyes of 10 patients undergoing transepithelial PRK Group B: 20 eyes of 10 patients undergoing LASIK using mechanical microkeratome Tear Break Up Time and Schirmer 2 tests are used to evaluate severity of dry eye before surgery and 1 , 3 and 6 months postoperative Follow up period : 6 months
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 6 months
Tear Break Up time is used as a qualitative measure of dry eye after surgery
Time frame: 6 months
Schirmer test is used as a quantitative measure of dry eye after surgery
Time frame: 6 months
haze is a known possible complication of surface ablation Its severity can be graded according to a slit lamp scoring system
Time frame: 2-5 days
the period of time in days needed for complete healing of the epithelial defect created during transepithelial PRK
Looking for future studies?
Notify MeAL-Nour Eye Hospital
Other
Evaluation of Dry Eye Following Transepithelial Photorefractive Keratectomy in Comparison to Conventional LASIK: a Comparative Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07298811
Dry Eye, Dry Eye Syndromes
Nanchang, Jiangxi, China
View Trial DetailsNCT04413370
Dry Eye, Dry Eye Syndromes
Guangzhou, Guangdong, China
View Trial DetailsNCT07175909
Dry Eye, Dry Eye Disease (DED)
Hong Kong
View Trial DetailsNCT07816419
Arthralgia, Asthenopia
Riyadh, Saudi Arabia
View Trial Details